SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 13, 2006
Diomed Holdings, Inc.
Delaware 000-32045 84-140636
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
1 Dundee Park
Andover, MA 01810
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (978-475-7771)
================================================================================
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
(b)
On July 10, 2006, Kevin Stearn resigned from his position as Managing
Director of Diomed, Ltd., a wholly-owned subsidiary of the Registrant located in
Cambridge, England. Mr. Stearn's resignation is effective September 29, 2006.
Diomed, Ltd. performs research and development and manufacturing functions
related to the Registrant's business. The U.K. operations will report to James
A. Wylie, Jr., Chief Executive Officer of the Registrant, until such time as Mr.
Stearn's replacement is named.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Diomed Holdings, Inc.
(Registrant)
Date: July 13, 2006 By: /s/ James A. Wylie
------------------------------------------
Name: James A. Wylie
Title: President and Chief Executive Officer